| 000 | 01746 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513230346.0 | ||
| 264 | 0 | _c20010510 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a1523-6838 | ||
| 024 | 7 |
_a10.1053/ajkd.2001.21293 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCharytan, C | |
| 245 | 0 | 0 |
_aEfficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. _h[electronic resource] |
| 260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cFeb 2001 |
||
| 300 |
_a300-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnemia, Iron-Deficiency _xdrug therapy |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 | _aErythrocyte Indices |
| 650 | 0 | 4 |
_aErythropoietin _xtherapeutic use |
| 650 | 0 | 4 |
_aFerric Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aFerric Oxide, Saccharated |
| 650 | 0 | 4 | _aGlucaric Acid |
| 650 | 0 | 4 |
_aHemoglobins _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aIron _xblood |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 700 | 1 | _aLevin, N | |
| 700 | 1 | _aAl-Saloum, M | |
| 700 | 1 | _aHafeez, T | |
| 700 | 1 | _aGagnon, S | |
| 700 | 1 | _aVan Wyck, D B | |
| 773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 37 _gno. 2 _gp. 300-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/ajkd.2001.21293 _zAvailable from publisher's website |
| 999 |
_c11096972 _d11096972 |
||